What is Alstem?
ALSTEM specializes in advanced biotechnology services, offering a comprehensive suite of products and solutions designed to accelerate scientific discovery. Their offerings include iPSC generation, gene editing, virus packaging, and custom cell line generation. Utilizing innovative tools such as HiBiT, HaloTag, NanoLuc, and NanoBiT, ALSTEM enables precise protein analysis crucial for research applications. The company is dedicated to serving the scientific community by providing tailored solutions that meet diverse research needs, emphasizing quality and rapid turnaround times to support researchers in their endeavors.
How much funding has Alstem raised?
Alstem has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Alstem
PPP
Public-Private Partnership
What's next for Alstem?
With the recent strategic investment, Alstem is poised for significant expansion and further innovation in its biotechnology service offerings. The substantial capital injection, part of its large-scale late-stage funding, suggests a focus on scaling operations, enhancing its product development pipeline, and potentially broadening its market reach. This financial backing will likely empower Alstem to further solidify its position as a key provider of advanced research tools and services, driving forward its mission to accelerate scientific breakthroughs in the biotechnology sector.
See full Alstem company page
